Nisa Investment Advisors’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$84.1K Sell
7,485
-35,165
-82% -$395K ﹤0.01% 1448
2025
Q1
$195K Sell
42,650
-131
-0.3% -$599 ﹤0.01% 1235
2024
Q4
$241K Buy
42,781
+35,214
+465% +$199K ﹤0.01% 1241
2024
Q3
$36.6K Sell
7,567
-147
-2% -$711 ﹤0.01% 1719
2024
Q2
$37.6K Buy
7,714
+6,949
+908% +$33.9K ﹤0.01% 1742
2024
Q1
$10.2K Buy
765
+107
+16% +$1.42K ﹤0.01% 2032
2023
Q4
$9.17K Sell
658
-2,122
-76% -$29.6K ﹤0.01% 2057
2023
Q3
$36.9K Sell
2,780
-40
-1% -$530 ﹤0.01% 1820
2023
Q2
$52.9K Buy
2,820
+1,489
+112% +$27.9K ﹤0.01% 1737
2023
Q1
$19K Hold
1,331
﹤0.01% 2028
2022
Q4
$26K Sell
1,331
-2
-0.2% -$39 ﹤0.01% 1981
2022
Q3
$50K Buy
1,333
+233
+21% +$8.74K ﹤0.01% 1738
2022
Q2
$17K Buy
+1,100
New +$17K ﹤0.01% 2092